Chylomicron retention disease (Anderson disease): A Patient Guide
At a Glance
Chylomicron retention disease is an inherited SAR1B condition that limits absorption of long-chain fats and fat-soluble vitamins. Lifelong low-fat nutrition, medium-chain triglycerides, vitamin supplements, and specialist monitoring can support growth and help prevent complications.
Chylomicron Retention Disease (CMRD), also known as Anderson disease, is an ultra-rare genetic condition that fundamentally changes how a child’s body interacts with long-chain dietary fats. At its core, the condition impairs the intestinal assembly and/or secretion of chylomicrons. While the intestines can take in dietary fats, a mutation in the SAR1B gene prevents the body from packaging and exporting these fats into the bloodstream where they are needed for energy and development [1][2].
This biological bottleneck typically reveals itself early in infancy or childhood. Most families first notice that their child is struggling to gain weight—a challenge known as failure to thrive—or is experiencing persistent digestive distress, such as chronic vomiting or greasy, foul-smelling stools. These symptoms occur because the body’s ability to absorb long-chain fats, essential fatty acids, and fat-soluble vitamins is markedly reduced. Because the condition is so rare, the journey to a correct diagnosis often involves ruling out more common digestive issues before identifying the underlying genetic cause [3][4].
Inheritance and Family Planning
CMRD is an autosomal recessive genetic condition. This means a child must inherit two mutated copies of the SAR1B gene (one from each parent) to have the disease. If both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of the child being a carrier (like the parents), and a 25% chance of the child inheriting neither variant. Families are encouraged to speak with a genetic counselor to review their specific variants and discuss testing for siblings [3].
The Lifelong Management Strategy
Living with CMRD requires a lifelong commitment to a specialized nutritional strategy. The cornerstone of management is a strict low-fat diet designed to minimize the amount of long-chain fat that remains in the intestines. To ensure the child still receives enough energy for growth, metabolic dietitians often prescribe medium-chain triglycerides (MCTs), a type of fat that bypasses the “broken” chylomicron pathway and enters the blood directly. Additionally, because the absorption of fat-soluble vitamins (A, D, E, and K) is severely impaired, specialized high-dose supplementation is required. Among these, Vitamin E is particularly critical to help protect against long-term damage to the nervous system and the eyes [4][5].
Monitoring and Outlook
While the diagnosis is permanent, consistent treatment substantially reduces the risk of long-term complications. Children with CMRD require individualized, regular monitoring by a specialized medical team to track their growth and keep a close watch on the health of their liver, nerves, and vision. Outcomes vary based on age at diagnosis, baseline deficiencies, and treatment response.
Important Safety Warning
While monitoring helps prevent complications, seek prompt medical advice if your child experiences:
- Persistent vomiting or diarrhea with signs of dehydration
- Unusual bruising or bleeding
- New balance or walking problems, or severe muscle weakness
- Changes in vision or night blindness
- Inability to keep fluids or prescribed supplements down
In this guide
5 chapters
Validation After Your Child's Diagnosis
Learn what a chylomicron retention disease diagnosis means for your child, why symptoms occur, and how specialist nutrition care and emergency records help
Recognizing the Signs of CMRD
Learn to recognize chylomicron retention disease symptoms in children, including greasy stools, vomiting, poor growth, vitamin deficiencies, and liver problems.
The Biology Behind the Diagnosis
Learn how CMRD affects intestinal fat transport, how SAR1B mutations cause chylomicron retention, and which blood, genetic, and biopsy tests support diagnosis.
Navigating Daily Treatment and Nutrition
Learn how chylomicron retention disease is managed with a low-fat diet, MCT oil, essential fats, and prescribed vitamins A, D, E, and K to support growth.
Lifelong Monitoring and Prevention
Learn how children with chylomicron retention disease are monitored for vitamin deficiencies, nerve and eye problems, liver health, growth, and warning signs.
Common questions in this guide
What is chylomicron retention disease?
What treatment does a child with CMRD need?
How is chylomicron retention disease inherited?
What symptoms can CMRD cause?
What warning signs require prompt medical advice?
How is a child with CMRD monitored?
Does chylomicron retention disease go away?
Get notified when new evidence is published on Chylomicron retention disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (5)
- 1
Chylomicron retention disease: genetics, biochemistry, and clinical spectrum.
Levy E, Poinsot P, Spahis S
Current opinion in lipidology 2019; (30(2)):134-139 doi:10.1097/MOL.0000000000000578.
PMID: 30640893 - 2
Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly.
Melville DB, Studer S, Schekman R
The Journal of biological chemistry 2020; (295(25)):8401-8412 doi:10.1074/jbc.RA120.012964.
PMID: 32358066 - 3
[Chylomicron retention disease caused by SAR1B gene variations in 2 cases and literatures review].
Zhang YQ, Wu LT, Cheng Y, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2024; (62(6)):565-570 doi:10.3760/cma.j.cn112140-20240301-00138.
PMID: 38763880 - 4
Case Report: Neonatal-onset chylomicron retention disease presenting as isolated failure to thrive with compound heterozygous SAR1B variants: the value of early genetic testing and challenges of long-term management.
Liu B, Zhang C
Frontiers in pediatrics 2026; (14()):1684900 doi:10.3389/fped.2026.1684900.
PMID: 41767779 - 5
Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia.
Cuerq C, Restier L, Drai J, et al.
Orphanet journal of rare diseases 2016; (11(1)):114 doi:10.1186/s13023-016-0498-8.
PMID: 27520363
This page is for informational purposes only and does not constitute medical advice. Your child’s metabolic specialist and dietitian should guide the diet, vitamin doses, genetic counseling, and monitoring plan.